×
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
LON:UDG

UDG Healthcare Share Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
1,079
1,079
52-Week Range
N/A
Volume
N/A
Average Volume
1.39 million shs
Market Capitalization
£2.72 billion
P/E Ratio
42.48
Dividend Yield
1.17%
Price Target
GBX 1,000

Receive UDG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for UDG Healthcare and its competitors with MarketBeat's FREE daily newsletter.

UDG Stock Forecast (MarketRank)

Overall MarketRank

1.92 out of 5 stars

Analyst Opinion: 3.0Community Rank: 4.9Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
UDG Healthcare logo

About UDG Healthcare (LON:UDG)

UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services. This segment supports healthcare professionals and patients at various stages of the product life cycle; and provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information, and event management services to approximately 300 healthcare companies. The Sharp segment provides contract and clinical trial packaging services for the pharmaceutical and biotechnology industries; serialization solutions; and clinical IRT services. The company was formerly known as United Drug plc and changed its name to UDG Healthcare plc in August 2013. UDG Healthcare plc was founded in 1948 and is heaquartered in Dublin, the Republic of Ireland.

UDG Stock News Headlines

UDG Healthcare(UDG)
See More Headlines

Industry, Sector and Symbol

Industry
Medical Distribution
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
9,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 1,000
High Stock Price Forecast
GBX 1,000
Low Stock Price Forecast
GBX 1,000
Consensus Rating
Hold
Rating Score (0-4)
2
Research Coverage
1 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£1.25 billion
Book Value
GBX 411.10 per share

Miscellaneous

Free Float
N/A
Market Cap
£2.72 billion
Optionable
Not Optionable
Beta
N/A














UDG Healthcare Frequently Asked Questions

Should I buy or sell UDG Healthcare stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for UDG Healthcare in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" UDG Healthcare stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in UDG, but not buy additional shares or sell existing shares.
View analyst ratings for UDG Healthcare
or view top-rated stocks.

What is UDG Healthcare's stock price forecast for 2022?

1 brokerages have issued 12 month price objectives for UDG Healthcare's stock. Their UDG stock forecasts range from GBX 1,000 to GBX 1,000. On average, they anticipate UDG Healthcare's share price to reach GBX 1,000 in the next year.
View analysts' price targets for UDG Healthcare
or view top-rated stocks among Wall Street analysts.

Is UDG Healthcare a good dividend stock?

UDG Healthcare(LON:UDG) pays an annual dividend of GBX 0.17 per share and currently has a dividend yield of 1.17%. The dividend payout ratio of UDG Healthcare is 0.67%. This payout ratio is at a healthy, sustainable level, below 75%.
View UDG Healthcare's dividend history.

Who are UDG Healthcare's key executives?

UDG Healthcare's management team includes the following people:
  • Mr. Brendan Patrick McAtamney, CEO & Exec. Director (Age 58, Pay $1.49M)
  • Mr. Nigel Clerkin, CFO & Exec. Director (Age 47, Pay $1.04M)
  • Mr. Ryan Quigley, Chief Operating Officer
  • Keith Byrne, Head of Investor Relations, Strategy & Corp. Communications
  • Eleanor Garvey, Group Head of Quality & Compliance
  • Mr. Damien Moynagh, Gen. Counsel & Company Sec.
  • Mr. Liam Logue, Exec. VP of Corp. Devel.
  • Ms. Lucy MacLauchlan-Wharton, Global Head of Marketing and Communications
  • Ms. Eimear Kenny, Exec. VP of HR (Age 51)
  • Mr. Tom Mitchell, Uk Head of Syndicated Services for Ashfield

What other stocks do shareholders of UDG Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other UDG Healthcare investors own include Carillion (CLLN), NBT Bancorp (NBTB), CRH (CRH), Standard Life Aberdeen (SL), BT Group - CLASS A (BT.A), Carclo (CAR), CBS (CBS), Greencore Group (GNC), Allergan (AGN) and Aviva (AV).

What is UDG Healthcare's stock symbol?

UDG Healthcare trades on the London Stock Exchange (LON) under the ticker symbol "UDG."

How do I buy shares of UDG Healthcare?

Shares of UDG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

How much money does UDG Healthcare make?

UDG Healthcare (LON:UDG) has a market capitalization of £0.00 and generates £1.25 billion in revenue each year.

How many employees does UDG Healthcare have?

UDG Healthcare employs 9,000 workers across the globe.

How can I contact UDG Healthcare?

UDG Healthcare's mailing address is River Walk 20, DUBLIN,, Ireland. The official website for UDG Healthcare is www.udghealthcare.com. The company can be reached via phone at +353-1-4689000.

This page (LON:UDG) was last updated on 6/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.